INS and obesity due to melanocortin 4 receptor deficiency: In Alström Syndrome, the metabolic alterations manifest early; reduced insulin-stimulated glucose disposal and hyperinsulinemia have been observed in patients as young as 1 year of age and can appear before the start of obesity in children, often evolving to type 2 diabetes during childhood, with variable age of onset [9], [28], [29].